Purple Biotech Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
PPBT
IL0007650166
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 14.12M 53.35M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.59% |
Managers | Title | Age | Since |
---|---|---|---|
Gil Efron
CEO | Chief Executive Officer | 57 | 18-10-10 |
Lior Fhima
DFI | Director of Finance/CFO | - | 22-11-01 |
Ido Morpurgo
COO | Chief Operating Officer | 51 | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Rowinsky
CHM | Chairman | 67 | 19-10-01 |
Yael Margolin
BRD | Director/Board Member | 70 | Dec. 19 |
Simcha Rock
BRD | Director/Board Member | 73 | 13-07-10 |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |